Thursday, 12 November 2026LatestVideosAboutContact
Latest
Most large firms plan higher open-weight AI use to cap bills, study showsHarshvardhan Rane buys luxury home worth Rs 15-16 crores in Mumbai: ReportAuqib Nabi shares advice from Rohit, Kohli and Gill ahead of New Zealand ODIsReliance plans ₹43,000 crore coal gasification project in Andhra PradeshHow potentials and electric fields together control reactions on catalyst surfacesBengaluru researcher among six Infosys Science Foundation prize winners for 2026Lupin launches biosimilar Ranibizumab through Sandoz in Europe except GermanyAmla and Bilva tree initiative launched by Santosh KumarKareena Kapoor Ayat-ul-kursi pendant row: Hindu outfit backs beboVirat Kohli and the art of not ceding an inchFrom multi-lingual AI agents to the future of voice: Google Cloud’s Naren Kachroo at TechSparks 2026Singapore’s Temasek to invest ₹2,500 crore in Godrej Capital
BusinessUpdated 16 min ago

Lupin launches biosimilar Ranibizumab through Sandoz in Europe except Germany

Image: BusinessLine

Ranluspec approved by European Commission in vial and pre-filled syringe forms for retinal disease treatment

Continue reading on BusinessLine

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all